Reversing Antibiotic Resistance with Inhibitors of Acetyltransferases - Azad, Marisa
46,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
23 °P sammeln
  • Broschiertes Buch

Hospitals worldwide are becoming increasingly plagued by antibiotic-resistant pathogens. The streptogramin and aminoglycoside antibiotics are drugs of last resort against life-threatening pathogens; however, as microbial drug resistance continues to emerge, the efficacy of these two important drug classes is decreasing. One of the most common mechanisms by which pathogens become resistant to streptogramin and aminoglycoside antibiotics is enzymatic inactivation: the Vat and AAC(3) acetyltransferases are employed by pathogens to inactivate streptogramin and aminoglycoside antibiotics,…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Hospitals worldwide are becoming increasingly plagued by antibiotic-resistant pathogens. The streptogramin and aminoglycoside antibiotics are drugs of last resort against life-threatening pathogens; however, as microbial drug resistance continues to emerge, the efficacy of these two important drug classes is decreasing. One of the most common mechanisms by which pathogens become resistant to streptogramin and aminoglycoside antibiotics is enzymatic inactivation: the Vat and AAC(3) acetyltransferases are employed by pathogens to inactivate streptogramin and aminoglycoside antibiotics, respectively. There is a dire need to not only develop new antibiotics, but to find strategies to outwit microbial resistance mechanisms. One of these strategies is to rescue the activity of antibiotics through the discovery of antibiotic adjuvants. In the current study, adjuvants which rescue the activity of streptogramin and aminoglycoside antibiotics through inhibition of the resistance acetyltransferases, VatD and AAC(3)-Ia, have been discovered-through the development of a cell-based screening method, we have found the first inhibitors of VatD, as well as of AAC(3)-Ia and its homologues.
Autorenporträt
O Dr. Azad completou o programa MD/PhD da Universidade McMaster em 2016. Obteve uma licenciatura em Biologia Celular, Molecular e Microbiana na Thompson Rivers University em 2010. Está actualmente a fazer uma residência de Medicina Interna na Universidade McMaster. A sua investigação visa encontrar inibidores de enzimas que as bactérias utilizam para inactivar os antibióticos.